-+ 0.00%
-+ 0.00%
-+ 0.00%

Aptevo Therapeutics announces at-the-market stock offering of up to $2.31 million

PUBT·11/02/2026 11:04:38
Listen to the news
Aptevo Therapeutics announces at-the-market stock offering of up to $2.31 million
  • Aptevo Therapeutics plans to offer up to $2.31 million in common stock under its existing at-the-market offering agreement.
  • Roth Capital Partners serves as sales agent under the agreement dated April 28, 2025.
  • Previous sales under the agreement totaled 303,157 shares, generating $11.8 million in gross proceeds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-442031), on November 02, 2026, and is solely responsible for the information contained therein.